Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients.
Pefloxacin (400 mg twice daily) was administered orally for infection prophylaxis in neutropenic patients. Diffusible fecal pefloxacin concentration was determined by bioassay during 24 neutropenic periods. The median diffusible fecal pefloxacin concentration was 187 micrograms/g. This concentration...
I tiakina i:
| I whakaputaina i: | Antimicrob Agents Chemother |
|---|---|
| Ngā kaituhi matua: | , , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
American Society for Microbiology (ASM)
1995
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162706/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7625811/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.5.1182 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
